Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice

[1]  T. Stone,et al.  Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine , 2015, Neuroscience.

[2]  L. Bekar,et al.  Acute systemic LPS-mediated inflammation induces lasting changes in mouse cortical neuromodulation and behavior , 2015, Neuroscience Letters.

[3]  C. Svensson,et al.  Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway. , 2015, Journal of psychiatry & neuroscience : JPN.

[4]  J. Guzowski,et al.  Systemic lipopolysaccharide administration impairs retrieval of context–object discrimination, but not spatial, memory: Evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation , 2015, Brain, Behavior, and Immunity.

[5]  C. Lim,et al.  A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality , 2015, Brain, Behavior, and Immunity.

[6]  Travis P. Todd,et al.  Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood , 2015, Frontiers in Behavioral Neuroscience.

[7]  Y. Osuga,et al.  IL‐1β Increases Expression of Tryptophan 2,3‐dioxygenase and Stimulates Tryptophan Catabolism in Endometrioma Stromal Cells , 2014, American journal of reproductive immunology.

[8]  L. Facci,et al.  Toll-Like Receptors 2, -3 and -4 Prime Microglia but not Astrocytes Across Central Nervous System Regions for ATP-Dependent Interleukin-1β Release , 2014, Scientific Reports.

[9]  G. Burnstock,et al.  Purinergic signalling and immune cells , 2014, Purinergic Signalling.

[10]  N. Castanon,et al.  Named Series : Diet , Inflammation and the Brain Diet-induced obesity progressively alters cognition , anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior : Focus on brain indoleamine 2 , 3-dioxygenase activation , 2014 .

[11]  Francis Loth,et al.  Systemic inflammation regulates microglial responses to tissue damage in vivo , 2014, Glia.

[12]  S Cichon,et al.  A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder , 2013, Molecular Psychiatry.

[13]  A. Kraneveld,et al.  Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice. , 2014, European journal of pharmacology.

[14]  T. Möller,et al.  Kynurenines in CNS disease: regulation by inflammatory cytokines , 2014, Front. Neurosci..

[15]  I. Schuppe-Koistinen,et al.  Imbalanced Kynurenine Pathway in Schizophrenia , 2014, International journal of tryptophan research : IJTR.

[16]  D. Bucci,et al.  The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia , 2013, Schizophrenia Research.

[17]  Klaus P. Ebmeier,et al.  CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. , 2013, Journal of affective disorders.

[18]  R. Dantzer,et al.  NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice , 2013, Neuropsychopharmacology.

[19]  R. Schwarcz,et al.  Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: Reversal with galantamine , 2013, Neuroscience.

[20]  P. Sklar,et al.  A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder , 2013, Molecular Psychiatry.

[21]  S. Janelidze,et al.  Connecting inflammation with glutamate agonism in suicidality , 2012, Neuropsychopharmacology.

[22]  J. Sheridan,et al.  Neural and behavioral responses to low-grade inflammation , 2012, Behavioural Brain Research.

[23]  L. Pont-Lezica,et al.  The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes , 2012, Journal of leukocyte biology.

[24]  M. Landén,et al.  Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder , 2012, Bipolar disorders.

[25]  J. O'Connor,et al.  Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge , 2012, Hormones and Behavior.

[26]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[27]  R. Schwarcz,et al.  Pre‐ and postnatal exposure to kynurenine causes cognitive deficits in adulthood , 2012, The European journal of neuroscience.

[28]  M. Holtze,et al.  Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. , 2012, Schizophrenia bulletin.

[29]  G. Guillemin.  Quinolinic acid: neurotoxicity , 2012, The FEBS journal.

[30]  G. Guillemin.  Quinolinic acid, the inescapable neurotoxin , 2012, The FEBS journal.

[31]  H. Hashimoto,et al.  Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: Possible role of activation of the central amygdala , 2012, Behavioural Brain Research.

[32]  S. Erhardt,et al.  Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice , 2012, Journal of Neural Transmission.

[33]  D. Bucci,et al.  Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats , 2011, Schizophrenia Research.

[34]  W. Banks,et al.  Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis , 2011, Brain, Behavior, and Immunity.

[35]  R. Schwarcz,et al.  Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. , 2011, Schizophrenia bulletin.

[36]  C. Cunningham,et al.  Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6 , 2011, Journal of Neuroinflammation.

[37]  M. Landén,et al.  Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder. , 2011, Journal of psychiatry & neuroscience : JPN.

[38]  T. Shirokawa,et al.  Shifts in the balance of brain tryptophan metabolism due to age and systemic administration of lipopolysaccharide , 2010 .

[39]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[40]  W. Banks,et al.  The blood–brain barrier and immune function and dysfunction , 2010, Neurobiology of Disease.

[41]  J. Schröder,et al.  Activation of brain interleukin-1β in schizophrenia , 2009, Molecular Psychiatry.

[42]  D. Bucci,et al.  L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning , 2009, Behavioural Brain Research.

[43]  Martin Samuelsson,et al.  Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity , 2009, Biological Psychiatry.

[44]  R. Dantzer,et al.  Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice , 2009, Molecular Psychiatry.

[45]  R. Dantzer,et al.  Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. , 2009, Journal of Neuroscience.

[46]  R. Dantzer,et al.  Induction of IDO by Bacille Calmette-Guérin Is Responsible for Development of Murine Depressive-Like Behavior1 , 2009, The Journal of Immunology.

[47]  Yaqin Tang.  Determination and clinical significance of serum kynurenine and kynurenic acid levels in schizophrenia , 2009 .

[48]  T. Shirokawa,et al.  Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice , 2009, Stress.

[49]  N. Ozaki,et al.  A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression , 2008, Stress.

[50]  S. Soinila,et al.  Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion , 2007, Neurochemistry International.

[51]  D. Bucci,et al.  Elevations of endogenous kynurenic acid produce spatial working memory deficits. , 2007, Schizophrenia bulletin.

[52]  D. Bucci,et al.  Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding , 2006, Behavioural Brain Research.

[53]  K. Blennow,et al.  Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia , 2005, Schizophrenia Research.

[54]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[55]  A. Świergiel,et al.  Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice , 2005, Pharmacology Biochemistry and Behavior.

[56]  M. Geyer,et al.  Endogenous kynurenic acid disrupts prepulse inhibition , 2004, Biological Psychiatry.

[57]  G. Dubyak,et al.  Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. , 2004, American journal of physiology. Cell physiology.

[58]  R. Dantzer,et al.  Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice , 2004, Brain, Behavior, and Immunity.

[59]  L. Clerkin,et al.  Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat , 2003, Neuropsychopharmacology.

[60]  R. Dantzer,et al.  The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen , 2002, Brain, Behavior, and Immunity.

[61]  J. Borrell,et al.  Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia , 2002, Neuropsychopharmacology.

[62]  K. Blennow,et al.  Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia , 2001, Neuroscience Letters.

[63]  R. Schwarcz,et al.  Increased cortical kynurenate content in schizophrenia , 2001, Biological Psychiatry.

[64]  F. Chiappelli,et al.  The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity , 2001, Journal of Neuroimmunology.

[65]  W. Banks,et al.  Effect of LPS on the permeability of the blood–brain barrier to insulin , 2001, Brain Research.

[66]  S. Rhee,et al.  Murine TOLL-like Receptor 4 Confers Lipopolysaccharide Responsiveness as Determined by Activation of NFκB and Expression of the Inducible Cyclooxygenase* , 2000, The Journal of Biological Chemistry.

[67]  S. Maier,et al.  Interleukin-1β in Immune Cells of the Abdominal Vagus Nerve: a Link between the Immune and Nervous Systems? , 1999, The Journal of Neuroscience.

[68]  F. Bloom,et al.  Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. , 1997, Journal of immunology.

[69]  R. Yirmiya.  Endotoxin produces a depressive-like episode in rats , 1996, Brain Research.

[70]  R. Schwarcz,et al.  Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia , 1988, Annals of neurology.

[71]  C. Blatteis,et al.  Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs , 1983, Brain Research Bulletin.

[72]  B. Baune,et al.  Effects of Centrally Administered Etanercept on Behavior, Microglia, and Astrocytes in Mice Following a Peripheral Immune Challenge , 2015, Neuropsychopharmacology.

[73]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.